Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
Ferrari A, De Salvo GL, Brennan B, van Noesel MM, De Paoli A, Casanova M, Francotte N, Kelsey A, Alaggio R, Oberlin O, Carli M, Ben-Arush M, Bergeron C, Merks JH, Jenney M, Stevens MC, Bisogno G, Orbach D. Ferrari A, et al. Among authors: ben arush m. Ann Oncol. 2015 Mar;26(3):567-72. doi: 10.1093/annonc/mdu562. Epub 2014 Dec 8. Ann Oncol. 2015. PMID: 25488687 Free article. Clinical Trial.
Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A, Chisholm JC, Jenney M, Minard-Colin V, Orbach D, Casanova M, Guillen G, Glosli H, van Rijn RR, Schoot RA, Cameron AL, Rogers T, Alaggio R, Ben-Arush M, Mandeville HC, Devalck C, Defachelles AS, Coppadoro B, Bisogno G, Merks JHM. Ferrari A, et al. Among authors: ben arush m. Lancet Child Adolesc Health. 2022 Aug;6(8):545-554. doi: 10.1016/S2352-4642(22)00121-3. Epub 2022 Jun 9. Lancet Child Adolesc Health. 2022. PMID: 35690071
Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study.
Schoot RA, Chisholm JC, Casanova M, Minard-Colin V, Geoerger B, Cameron AL, Coppadoro B, Zanetti I, Orbach D, Kelsey A, Rogers T, Guizani C, Elze M, Ben-Arush M, McHugh K, van Rijn RR, Ferman S, Gallego S, Ferrari A, Jenney M, Bisogno G, Merks JHM. Schoot RA, et al. Among authors: ben arush m. J Clin Oncol. 2022 Nov 10;40(32):3730-3740. doi: 10.1200/JCO.21.02981. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709412 Free PMC article. Clinical Trial.
Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution.
Orbach D, André N, Brecht IB, López Almaraz R, Ben-Ami T, Vermersch S, Carton M, Virgone C, Bisogno G, Schneider DT, Bajciova V, Reguerre Y, Galateau-Salle F, Stachowicz-Stencel T, Dvir R, Rees H, Bien E, Ferrari A, Ben Arush M. Orbach D, et al. Among authors: ben ami t, ben arush m. Eur J Cancer. 2020 Nov;140:63-70. doi: 10.1016/j.ejca.2020.09.011. Epub 2020 Oct 10. Eur J Cancer. 2020. PMID: 33049597
Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
Ben-Arush M, Minard-Colin V, Scarzello G, Fajardo RD, Terwisscha Van Scheltinga S, Bernier V, Jenney M, Gallego S, Zanetti I, Cesen M, Merks JHM, Bisogno G. Ben-Arush M, et al. Eur J Cancer. 2022 Sep;172:119-129. doi: 10.1016/j.ejca.2022.05.033. Epub 2022 Jun 25. Eur J Cancer. 2022. PMID: 35763871
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A; European paediatric Soft tissue sarcoma Study Group. Bisogno G, et al. Among authors: ben arush m. Lancet Oncol. 2019 Nov;20(11):1566-1575. doi: 10.1016/S1470-2045(19)30617-5. Epub 2019 Sep 24. Lancet Oncol. 2019. PMID: 31562043 Clinical Trial.
Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments.
Chargari C, Haie-Meder C, Espenel S, Garcia MA, Ben-Arush M, Bolle S, Borjesson A, Cesen M, Lago RC, Defachelles AS, De Moerloose B, Devalck C, Edslev P, Farinha NJ, Francotte N, Glosli H, Gouy S, Burrieza GG, Helfre S, Irtan S, Kattamis A, Lacerda A, Levy A, Hjalgrim LL, Mansuy L, Mascard E, Moalla S, Orbach D, Owens C, Philippe-Chomette P, Pizer B, Pluchart C, Renard M, Rognlien AGW, Rome A, Sarnacki S, Safwat A, Schiavetti A, Serre J, Verite C, Weid NV, Wysocki M, Valteay-Couanet D, Deutsch E, Minard-Colin V, Martelli H, Guérin F. Chargari C, et al. Among authors: ben arush m. Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):602-613. doi: 10.1016/j.ijrobp.2022.03.003. Epub 2022 Mar 9. Int J Radiat Oncol Biol Phys. 2022. PMID: 35278672
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, Carli M, Stevens M, Kelsey A, De Paoli A, Gaze MN, Martelli H, Devalck C, Merks JH, Ben-Arush M, Glosli H, Chisholm J, Orbach D, Minard-Colin V, De Salvo GL; European paediatric Soft tissue sarcoma Study Group. Bisogno G, et al. Among authors: ben arush m. Lancet Oncol. 2018 Aug;19(8):1061-1071. doi: 10.1016/S1470-2045(18)30337-1. Epub 2018 Jun 22. Lancet Oncol. 2018. PMID: 29941280 Clinical Trial.
134 results